Funder: PRONACERA THERAPEUTICS SL
date_range Duration: from 07 March 2022 to 06 March 2023 (12 months) Finished
euro 5,998.40 EUR

Of National scope. With a Private character.

Call: (PRONACERA THERAPEUTICS SL)

Researchers